v3.26.1
EQUITY TRANSACTIONS (Tables)
12 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Schedule of warrant activity
                
   Fiscal Year Ended March 31, 
   2026   2025 
   Warrants   Weighted
Average
Exercise Price
   Warrants   Weighted
Average
Exercise Price
 
Outstanding, beginning of year   235,712   $35.55    409   $200.90 
Granted   1,955,126   $5.36    361,550   $35.80 
Exercised   (210,555)  $24.38    (123,131)  $39.20 
Cancelled/Forfeited   (22,793)  $46.40    (3,116)  $250.13 
Outstanding, end of year   1,957,490   $6.48    235,712   $35.55 
Exercisable, end of year   1,957,490   $6.48    235,712   $35.55 
Weighted average estimated fair value of warrants granted       $N/A        $N/A 
Schedule of warrant activity exercisable and outstanding
            
   Warrants Outstanding 
Range of
Exercise Prices
  Number
Outstanding
   Weighted
Average
Remaining
Life (Years)
   Weighted
Average
Exercise Price
 
$9.00 or Below   1,899,572    4.99   $5.26 
$46.40   57,918    3.13   $46.40 
    1,957,490           

 

The detail of the warrants outstanding and exercisable as of March 31, 2025 is as follows:

             
   Warrants Outstanding and Exercisable 
Range of
Exercise Prices
  Number
Outstanding
   Weighted
Average
Remaining
Life (Years)
   Weighted
Average
Exercise Price
 
$46.4 or Below   235,712    4.63   $35.50 
    235,712           
Schedule of options outstanding that have vested and are expected to vest
             
   Number of
Shares
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term in
Years
 
Vested   659   $1,305.04    5.12 
Expected to vest      $     
Total   659           
Schedule of stock option activity
                
   Fiscal Year Ended March 31, 
   2026   2025 
   Options   Weighted
Average
Exercise Price
   Options   Weighted
Average
Exercise Price
 
Outstanding, beginning of year   659   $1,305.04    1,086   $1,462.20 
Granted      $       $ 
Cancelled/Forfeited      $    (427)  $1,702.90 
Outstanding, end of year   659   $1,305.04    659   $1,305.04 
Exercisable, end of year   659   $1,305.04    583   $1,328.20 
Weighted average estimated fair value of options granted       $N/A        $N/A 
Schedule of nonvested shares
        
   Shares   Weighted Average Grant Date Fair Value 
Nonvested stock options at April 1, 2025   76   $1.37 
Vested   (76)  $1.37 
Forfeited      $ 
Nonvested stock options at March 31, 2026         
Schedule of detail of options outstanding and exercisable by exercise price
                               
    Options Outstanding     Options Exercisable  
Exercise Prices   Number
Outstanding
    Weighted
Average
Remaining
Life (Years)
    Weighted
Average
Exercise
Price
    Number
Outstanding
    Weighted
Average
Exercise
Price
 
$1024.00-1,128.00     507       6.22 years     $ 1,092.00       431     $ 1,085.00  
$2,016.00     152       5.76 years     $ 2,016.00       152     $ 2,016.00  
Total     659                       583          
Schedule of RSUs
    
   Shares 
Nonvested RSUs at April 1, 2025    
Granted   7,143 
Vested   (7,143)
Nonvested RSUs at March 31, 2026    
Schedule of stock-based compensation
        
   Fiscal Year Ended 
   March 31, 2026   March 31, 2025 
Vesting of restricted stock units  $200,000   $218,750 
Vesting of stock options   78,547    196,484 
Total Stock-Based Compensation  $278,547   $415,234